For example, virus attachment, DNA replication, protein synthesis or encapsulation of the virus.African Swine Fever virus does not form what we call plaques, which means that we can not see under the microscope whether the virus is replicating or not.
So, we had to produce a recombinant African Swine Fever virus which expresses green fluorescent protein (GFP), a reporter gene.We have isolated that virus.
So, what that gives us is that, when we treat the cells and then infect those cells with the GFP expressing virus we can measure the virus replication by visualizing the difference in number of cells expressing green signal (treated vs non treated cells) under the microscope.
Dr. Tikoo says researchers are using high throughput screening in vitro (in tissue culture) in the CFIA approved level 3 lab at VIDO's International Vaccine Center in hopes of identifying a few antiviral compounds that merit further testing in vivo (in live animals).He expects to have results of the in vitro testing within four to five months.For more visit Farmscape.Ca.
Source : Farmscape.ca